Ahmed Awad

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics”.

COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: baseline clinical characteristics

Nephrology Dialysis Transplantation(2025)10.1093/ndt/gfaf022

N/A

0.532DataRank · unranked

22 citations

Jennifer B. Green, Hiddo J.L. Heerspink, Johannes F.E. Mann, Janet B. McGill, Amy K. Mottl +94 more

Increased plasma concentrations of 6-oxo-methylphenidate in CES1 G134E carriers following a single oral dose of methylphenidate

Medicinal Chemistry Research(2025)10.1007/s00044-025-03477-3

N/A

0DataRank · unranked

0 citations

Philip W. Melchert, Ahmed Awad, Christopher R. McCurdy, Beth Krone, Jeffrey Newcorn +6 more